Keratoconus can make vision correction more complicated because the cornea becomes thinner and gradually develops an irregular, cone shaped contour. Traditional laser vision procedures are not generally designed for corneas that are changing in this way.
Corneal crosslinking has provided an important treatment option by strengthening the corneal tissue and helping stop the progression of keratoconus. After the cornea has reached a stable state following crosslinking, some carefully selected patients may be considered for PRK to improve the vision problems that remain.
Waite Vision now offers this approach for qualifying patients in Utah.
The first priority when treating progressive keratoconus is to stabilize the cornea. Crosslinking uses a combination of riboflavin and ultraviolet light to strengthen connections within the corneal tissue. Its purpose is to slow or stop the progression of the condition rather than directly correct the vision prescription.
PRK involves reshaping the cornea, so accurate and consistent measurements are essential when creating a treatment plan. Performing laser correction while keratoconus is still progressing could produce an unpredictable result because the shape of the cornea may continue to change after treatment.
Contact Details
Waite Vision
3333 Digital Dr #300, Lehi, UT 84043
(801) 876-6000
Website: https://www.waitevision.com/prk-utah/
Google Site: https://sites.google.com/view/waitevision/prk-utah
Google Folder: https://mgyb.co/s/iVOuq
For this reason, patients are usually monitored for a period following crosslinking before PRK is considered. The surgical team needs evidence that the corneal shape has become stable and that measurements are sufficiently consistent to support further treatment.
This waiting period is an important part of protecting the cornea and developing an appropriate treatment strategy.
When PRK is considered after crosslinking, the objective is generally to improve the remaining visual distortion rather than completely correct every aspect of keratoconus. Some patients continue to experience irregular astigmatism or other refractive errors even after the underlying progression has been stabilized.
A conservative PRK treatment may reduce some of these remaining irregularities and improve functional vision. The amount of tissue removed is carefully limited because preserving corneal strength remains an important consideration for someone with a history of keratoconus.
Treatment is customized according to the shape and condition of each individual cornea. Detailed corneal imaging and topography help the surgeon understand where irregularities remain and whether they can be safely addressed. Measurements collected over time can also help demonstrate that the cornea has maintained a stable pattern after crosslinking.
Having undergone crosslinking does not automatically make someone eligible for PRK. Candidacy depends on several factors that must be evaluated during a detailed examination.
The cornea needs to demonstrate stability after crosslinking, and there must be sufficient tissue available for the proposed treatment. The remaining refractive error also needs to be suitable for a conservative PRK approach. Some patients may have corneal irregularities or thinning that make laser treatment inappropriate even after their keratoconus has stabilized.
Corneal mapping plays an important role in this decision. Rather than relying only on a standard glasses prescription, the surgeon examines the shape, thickness, and surface characteristics of the cornea. These measurements help determine whether treatment can be performed while maintaining an appropriate level of structural safety.
Waiting for stabilization can be difficult for patients who have already spent years managing keratoconus. However, the period following crosslinking gives the surgical team an opportunity to determine whether the cornea is actually holding its new shape.
Measurements taken at different appointments can be compared to look for meaningful changes. If the corneal shape continues to shift, additional time may be needed before PRK can be considered. Moving ahead before stability has been established could mean designing the laser treatment around measurements that later change.
Regular monitoring allows the surgeon to follow the cornea without unnecessarily delaying the evaluation once stability has been demonstrated. Follow up imaging can provide useful information about whether the eye is progressing toward a consistent and predictable pattern.
PRK after crosslinking requires a different level of consideration than a typical laser vision correction case. The treatment needs to account for the patient's previous keratoconus and the structural characteristics of the cornea.